January 31, 2025
3 min watch
Save
VIDEO: Qlosi improves functional near vision in presbyopia
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Paul Smith of Orasis Pharmaceuticals discusses the benefits that Qlosi provides patients with presbyopia.
Smith said that Qlosi (pilocarpine hydrochloride ophthalmic solution 0.4%) is “very well tolerated” overall, and in clinical studies, it demonstrated positive real-world endpoints in functional near vision.
“We’re very excited to be bringing that to the market here over the next several weeks,” he said.
Published by:
Sources/Disclosures
Collapse
Source:
Smith P. Orasis Pharmaceuticals. Healio | OSN’s disruptive innovations. Presented at: Hawaiian Eye 2025; Jan. 18-24, 2025; Koloa, Hawaii.
Disclosures:
Smith reports being president and chief operating officer at Orasis Pharmaceuticals.
Read more about